CMCO

In the past six months, CMCO's stock was impacted by several events: On July 30, 2026, the company reported record orders and sales for Q1 FY27 and increased its FY27 guidance, leading to a +41.45% stock gain. Prior to this, on June 4, 2026, CMCO delivered 20% order growth and 24% net sales growth in FY26, issued FY27 guidance, and reported a net loss of $230 million (including a $200 million non-cash goodwill impairment), with analysts suggesting the stock might be undervalued. In Q2 CY2026, revenue was $531.5 million, beating estimates by 5.9% with 125% year-on-year growth, and adjusted EPS was $0.61, significantly beating estimates. On September 22, 2026, the repricing of its $1.453 billion Term Loan B and $500 million Revolving Credit Facility resulted in a +5.80% stock price change. Over the last three months, insiders bought a net of $194,660.00 in company stock, with no insider selling, indicating management confidence. Analyst ratings saw changes, with Zacks Research downgrading CMCO to 'Hold' from 'Strong Buy' on October 8, 2026, and Wall Street Zen downgrading shares from 'buy' to 'hold' on June 13th. Lastly, on July 20, 2026, Columbus McKinnon declared a quarterly dividend of $0.07 per share.